Zymeworks, Inc. (ZYME)
23.29
-0.52
(-2.18%)
USD |
NASDAQ |
Feb 27, 16:00
23.32
+0.03
(+0.13%)
After-Hours: 20:00
Zymeworks Research and Development Expense (TTM) : 142.83M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Vertex Pharmaceuticals, Inc. | 3.929B |
| Krystal Biotech, Inc. | 55.08M |
| Scholar Rock Holding Corp. | 210.30M |
| Stoke Therapeutics, Inc. | 117.76M |